T1	Intervention 11 47	sodium and potassium supplementation
T2	Intervention 227 263	sodium and potassium supplementation
T3	Intervention 501 678	received capsules with supplemental sodium (3 g d(-1), equals 7.6 g d(-1) of salt), supplemental potassium (3 g d(-1)) or placebo, for 4 weeks each, in random order.
T4	Intervention 679 787	Fasting office BP, 24-h ambulatory BP and measures of arterial stiffness were assessed at baseline and every
T5	Intervention 1071 1093	compared with placebo.
T6	Intervention 1094 1100	During
T7	Intervention 1218 1249	central BP by 8.5/3.6 mm Hg
T8	Intervention 1409 1459	augmentation index were not significantly affected
